FRAX486

FRAX486

Catalog Number:
L002371471APE
Mfr. No.:
APE-B6165
Price:
$209
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          IC50: 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively
          FRAX486 is a p21-activated kinase (PAK) inhibitor.
          PAKs are known as effector proteins for the Rho GTPases Cdc42 and Rac. Both in vitro and in vivo studies have showed PAKs play critical roles for cytoskeletal organization and in various aspects of cell growth and development.
          In vitro: Previous study showed in WPMY-1 cells, FRAX486 could dose-dependently induce the degeneration of actin filaments, which was accompanied by proliferation rate attenuation. Moreover, the FRAX486 cytotoxicity in WPMY-1 cells was found to be both time- and concentration-dependent. In addition, the effects of FRAX486 on actin organization, survival, and proliferation were observed at 1-5 μM in WPMY-1 cells, and complete inhibition of PAK1-3 might be expected, whereas PAK4 might be inhibited only partially at these concentrations [1].
          In vivo: Animal study found that FRAX486 was able to cross the blood-brain barrier (BBB) and the brain therapeutical FRAX486 concentrations were detected as early as 1 h and remained as long as 24 h, with the maximum concentration (Cmax) at 8 h. Moreover, FRAX486 could reduce hyperactivity and stereotypical movements, both of which were phenotypes characterizing the Fragile X syndrome mouse model [2].
          Clinical trial: Up to now, FRAX486 is still in the preclinical development stage.

          [1] Wang Y,et al. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate. PLoS One. 2016 Apr 12;11(4):e0153312.
          [2] Dolan BM,Duron SG,Campbell DA,Vollrath B,Shankaranarayana Rao BS,Ko HY,Lin GG,Govindarajan A,Choi SY,Tonegawa S. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5671-6.

      • Properties
        • Alternative Name
          6-(2,4-dichlorophenyl)-8-ethyl-2-((3-fluoro-4-(piperazin-1-yl)phenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
          CAS Number
          1232030-35-1
          Molecular Formula
          C25H23Cl2FN6O
          Molecular Weight
          513.39
          Appearance
          Yellow solid
          Purity
          98.00%
          Solubility
          insoluble in H2O; insoluble in DMSO; insoluble in ETOH
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    MI-136

    $461

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.